D-341-2014 Class III Terminated

Recalled by Sandoz Inc — Wilson, NC

FDA drug recall D-341-2014 was initiated by Sandoz Inc on Nov 6, 2013 and is designated Class III. Reason for recall: Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions. The recall status is terminated (terminated May 29, 2014). Affected quantity: 11,496 bottles (100 count) and 62 bottles (500 count).

Recall details

Product Type
Drugs
Report Date
Dec 18, 2013
Initiation Date
Nov 6, 2013
Termination Date
May 29, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,496 bottles (100 count) and 62 bottles (500 count)

Product description

Bumetanide Tablets USP 0.5 mg. Rx Only, a) 100-count Bottle, b) 500-count Bottle, Sandoz Inc., Princeton, NJ 08540, NDC a) 0185-0128-01, b) 0185-0128-05

Reason for recall

Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.

Distribution pattern

Nationwide

Code information

Lot #: a) CU6131, b) CW1161

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-341-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-341-2014. Report a data issue: hello@regdatalab.com.